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Abstract: 
Background: Antimicrobial stewardship (AMS) provides a means of tackling antimicrobial resistance (AMR). 
Unfortunately, in Nigeria, like in some other low-and-middle-income countries (LMICs), AMS practice has been 
lacklustre due to poor institutional support amongst other factors. Efforts were made to address this situation by 
engaging with the management of National Hospital Abuja, Nigeria, using antibiotic prescription information 
obtained through repeated point prevalence survey.                                                      
Methodology: Two rounds of antibiotic PPS were conducted in 2015 and 2017 using the Global Point Prevalence 
Survey (G-PPS) format. Data were collected from all inpatients receiving antibiotics on the selected day of study, 
including patient characteristics, antimicrobial prescription details, laboratory results and information on a set of 
quality indicators. The data were uploaded to an online G-PPS application hosted at the University of Antwerp in 
Belgium for validation, analysis and reporting.                          
Results: The PPS data showed that hospital-wide antibiotic use prevalence increased from 58% in 2015 to 61% 
in 2017. Surgical prophylaxis beyond 24 hours also increased from 88-90% in 2015 to 100% in 2017, and only 
minority of therapies were supported by laboratory input for diagnosis and monitoring; 22% in 2015 and 5% in 
2017.                         
Conclusion: These results were used for evidence-based engagement with the management to formally support 
AMS activities in the hospital. Positive outcomes were the formal reconstitution and inauguration of AMS 
committee in 2018 as well as the issuance of a formal policy statement by the hospital in 2020. The ease and 
free availability of Global PPS methodology makes it ideal in driving antimicrobial stewardship programme (ASP) 
in LMICs like Nigeria.  
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Abstrait: 
Contexte: La gestion des antimicrobiens (AMS) offre un moyen de lutter contre la résistance aux antimicrobiens 
(RAM). Malheureusement, au Nigéria, comme dans certains autres pays à revenu faible ou intermédiaire (PRFI), 
la pratique de la MGS a été médiocre en raison d'un soutien institutionnel insuffisant, entre autres facteurs. Des 




efforts ont été faits pour remédier à cette situation en collaborant avec la direction de l'hôpital national d'Abuja, 
au Nigéria, en utilisant les informations sur les prescriptions d'antibiotiques obtenues grâce à une enquête 
ponctuelle répétée de prévalence.                                
Méthodologie: Deux séries d'antibiotiques PPS ont été menées en 2015 et 2017 en utilisant le format Global 
Point Prevalence Survey (G-PPS). Des données ont été recueillies auprès de tous les patients hospitalisés recevant 
des antibiotiques le jour sélectionné de l'étude, y compris les caractéristiques des patients, les détails de la 
prescription d'antimicrobiens, les résultats de laboratoire et les informations sur un ensemble d'indicateurs de 
qualité. Les données ont été téléchargées sur une application en ligne G-PPS hébergée à l'Université d'Anvers en 
Belgique à des fins de validation, d'analyse et rapports.                              
Résultats: Les données PPS ont montré que la prévalence de l'utilisation d'antibiotiques à l'échelle de l'hôpital 
est passée de 58% en 2015 à 61% en 2017. La prophylaxie chirurgicale au-delà de 24 heures est également 
passée de 88 à 90% en 2015 à 100% en 2017, et seule une minorité de thérapies a été soutenue par entrée de 
laboratoire pour le diagnostic et la surveillance; 22% en 2015 et 5% en 2017.                  
Conclusion: Ces résultats ont été utilisés pour un engagement fondé sur des données probantes avec la direction 
afin de soutenir officiellement les activités AMS à l'hôpital. Les résultats positifs ont été la reconstitution formelle 
et l'inauguration du comité AMS en 2018 ainsi que la publication d'une déclaration de politique formelle par 
l'hôpital en 2020. La facilité et la disponibilité gratuite de la méthodologie Global PPS la rend idéale pour conduire 
le programme de gestion des antimicrobiens (ASP) en PRFI comme le Nigéria. 
Mots clés: liste de contrôle pour la gestion des antibiotiques, soutien institutionnel, enquête ponctuelle de 
prévalence, déclaration de politique 
Introduction:   
 
 The role of organisational support is 
emphasised by the dedication of a section of 
both the WHO and CDC checklists of essential 
healthcare facility core elements for anti- 
microbial stewardship programme (AMS) to 
leadership, accountability and responsibilities 
(1,2). In certain situations, the support may 
be impaired by the management setting up 
AMS or selecting teams without recourse to 
the internationally recognised guidelines. 
AMS, a recognised systematic strategy to 
prevent and control the emergence of anti- 
microbial resistance (AMR) is most effective 
when applied under a structured organisa- 
tional arrangement (3,4). The creation and 
sustenance of this structure is strongly 
dependent on robust organisational support 
for AMS and plays a major role in determining 
the outcome of AMS interventions (4,5). Such 
organisational and management support 
includes formal recognition of the necessity to 
set up AMS committee, allocation of budget, 
and appointment of persons with requisite 
qualifications and experience to oversee AMS 
programme.      
 A common factor in low-and-middle-
income-countries (LMICs) is the relatively low 
level of antimicrobial use (AMU) information 
and the related low level of AMS activity 
(6,7,8). Evidence, scientifically obtained and 
analysed, is the best way to provide proof of a 
problem. In the case of AMS, the prevalence 
and pattern of antimicrobial prescription are 
means to convince institution management of 
the problem of AMR (1,4,9,10,11) and engage 
in conversation on strategies for its contain- 
ment, especially in the form of a formal policy 
committing to AMS (4,5,6,8). This is further 
bolstered when such scientific evidence is from 
within the institution.    
 Periodic assessment of antimicrobial 
prescription using PPS presents a simple, 
objective and comprehensive methodology (1, 
4,10). This information can be analysed and 
the results communicated and disseminated to 
key stakeholders to drive AMS (6,8). The aim 
of this study is to determine the antimicrobial 
prescription patterns among inpatients in the 
hospital through PPS and use this information 
to improve management support for AMS 
activity in National Hospital, Abuja, Nigeria. 
 
Materials and method: 
 
Study setting    
 This study was carried out in National 
Hospital, a 450-bed tertiary centre located in 
Abuja, Northcentral Nigeria. The hospital 
provides general services for adult (medical 
and surgical) and paediatric (medical and 
surgical) as well as a wide range of specialist 
diagnostic and intervention services including 
intensive care, trauma, oncology, and haema- 
tology among others. 
 
Method of PPS    
 Two rounds of antibiotic PPS were 
conducted in 2015 and 2017 using Global-PPS 
format developed by the University of Antwerp 
(www.global-pps.com). Briefly, AMS data were 
collected from all inpatients on ward admission 
at 8:00 hours on the selected days of study in 
2015 and 2017, but surgical wards were not 
surveyed on Mondays and Fridays, and all 
patients admitted after 08.00hrs were exclu- 
ded from the survey.    
 All inpatients on the day of the survey 
formed the denominator while all inpatients 
who had any antimicrobial treatment at the 
time of the survey formed the numerator. 
Information was gathered on antimicrobial use 
including prescription, indication and route of 
intake. Other information collected included 
but not limited to; age, gender, diagnosis, 
stop/review date, adherence to guidelines and 
laboratory results. The data were entered into 




the G-PPS online application software of the 
University of Antwerp in Belgium for analysis.  
 
Measurement of AMS activity in the hospital
 The level of AMS activity in the 
hospital was objectively assessed annually 
from 2017 to 2020 using an AMS assessment 
toolkit adapted from the WHO and CDC 
checklists of essential healthcare facility core 
elements for AMS programmes (1,2). This kit 
assigned scores for various elements of AMS 
activity grouped into sections covering 
‘leadership commitment’, ‘accountability and 
responsibilities’, ‘AMS actions’, ‘education and 
training’, ‘monitoring and surveillance’, and 
‘reporting and feedback’. The values obtained 
were used to measure changes in AMS activity 
within the hospital.  
Results: 
Antibiotic prevalence patterns:   
 The PPS results across adult (medical, 
surgical, obstetrics and gynaecology) and 
paediatric (medical and surgical) wards, and 
intensive care unit (ICU) showed that there 
was a hospital wide increase in prevalence of 
antibiotic use from 58% in 2015 to 61% in 
2017.      
 The pattern of surgical prophylaxis 
showed that prescription beyond 24 hours 
increased from 88-90% in 2015 to 100% in 
2017. Only a minority of cases had evidence 
of targeted therapy based on laboratory input 
for diagnosis and monitoring with 22% in 2015 
and 5% in 2017 (Table 1). 
Quality indicators:    
 Majority of prescriptions were via the 
parenteral route in both years surveyed (70% 
in 2015 and 82% in 2017) and 55% and 50% 
of patients were on two or more antibiotics in 
2015 and 2017 respectively. Documentation 
of stop/review dates varied across the wards 
and ICU but in both years, it was lowest in the 
ICU (0% in 2015 and 10% in 2017) while 
documentation of reasons for therapy in notes 
was highest in the same ICU (97% in 2015 and 
57% in 2017). 
AMS activity:     
 The use of the toolkit adapted from 
the WHO AMS (1) showed that there was an 
improvement in AMS activity particularly in 
the sections covering ‘leadership and commit- 













Antibiotic prevalence in percentage 
 
58 61 
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Quality indicators Parenteral route in percentage 
 
70 82 
On > 2 antibiotics in percentage 
 
55 50 
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Fig 1: Time-line of AMS activities following presentation of Global-PPS reports to National Hospital management 
Discussion: 
 The antimicrobial prescription rates in 
our institution for 2015 and 2017 (58% and 
61%) were higher than the worldwide average 
of 34.4% (12). Rates are significantly lower in 
countries where AMS activities have been 
actively pursued such as the Netherlands and 
Belgium with rates at 22.9% and 27.1% 
respectively (13,14). This would suggest that 
antimicrobial misuse may be similarly high in 
this setting as it is linked to high prevalence 
rates (15). This was supported by the high 
levels of inappropriate surgical prophylaxis 
(88 -90%) which is far higher than 40.6-
86.3% worldwide average (12). On the other 
hand, prevalence of targeted therapy (22% 
and 5%), stop/review dates (range 0-82%) 
and documented reasons for therapy in case 
notes (97% and 57%) were comparable to the 
global average of 19.8%, 38.3% and 76.9% 
for these parameters respectively (12). 
 These results suggest the extent of 
poor antimicrobial utilisation in our institution 
and the need for a robust antimicrobial 
stewardship programme. While the problem 
exists in more developed climes, efforts to 
establish AMS in many LMICs more often 
suffer from lack of institutional support (6,7). 
This has been demonstrated as major 
limitation to AMS activity in Nigerian 
healthcare institutions by Iregbu et al (16). In 
LMICs, AMS interventions are more effective 
when there is institutional support (17). An 
institution management does not necessarily 
set out to deny AMS the supports that it needs, 
however when there are competitions in the 
allocation of resources between overtly 
revenue generating hospital activities and 
non-revenue generating ones such as AMS, 
the latter usually gets short changed (8). 
Often AMS has failed to make a convincing 
case for itself and justify the resources it 
deserves from the management without which 
it cannot function (5,8). Behavioural change 
has been demonstrated to be one of the most 
difficult things to achieve but persistent 
reinforcement of the message increases the 
chances for success (11,18). This applies 
when trying to persuade managers and 
prescribers in healthcare providing institutions 
of the need to formally incorporate it into their 
healthcare policy and adopt new prescribing 
behaviours respectively (9).   
 The effectiveness of the AMS 
committee set up by our institution in 2012 
was impaired by management’s lukewarm 
support to AMS activities with no formal 
commitment or acknowledgement of AMR as 
an issue. Additionally, the committee was 
selected without adequate representation 
from key stakeholders. Information on anti- 
microbial prescription was needed to create 
local evidence for change.  The results of our 
longitudinal Global-PPS were used for evid- 
ence-based engagement with the hospital 
management, which was done by presenting 
the PPS results to key policy makers and key 
stakeholders. Multiple opportunities were 



















including management meetings and grand 
rounds. Positive outcomes of these were the 
formal reconstitution and inauguration of AMS 
committee in 2018.    
 The management of the hospital used 
internationally accepted criteria in selecting 
the AMS committee makeup and clear terms 
of reference were issued. The current commi- 
ttee is multidisciplinary with key stakeholders 
under a qualified leadership of a consultant 
microbiologist with infectious disease training, 
and physicians, pharmacist and nurse as 
members. This is in line with recommended 
best practice (1). Additionally, office space 
was provided, and significantly, the AMS 
committee has formed a collaboration with the 
infection prevention and control (IPC) team. 
Furthermore, the hospital charged a team 
made up of upper management and experts 
experienced in AMS, with creating a policy 
statement on AMS in 2019. This document was 
reviewed and released by the top mana- 
gement as a formal policy statement in early 
2020. This is one measure recommended by 
MacDougall and Polk to improve the chances 
of AMS achieving any measure of success (6).  
Conclusion:  
 Institutional support is more forth- 
coming when evidence of antimicrobial misuse 
within the system is provided and used to 
engage management. The ease of Global PPS 
methodology makes it ideal in driving ASP in 
LMICs like Nigeria. AMS professionals should 
undertake PPS and use this to enhance formal 
institutional support for AMS. As more 
institutions adopt AMS, it behoves healthcare 
personnel to ensure its success by carrying out 
PPS and using it as evidence for AMS. 
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